Seven days after tumor inoculation (designated as day 0), the mice were randomized into six groups: G1, PBS; G2, anti-CD47 antibodies (Anti-CD47ab); G3, Fe-Bac-HlpA/EGFP-BLPs + AMF; G4, Fe-Bac-HlpA/CD47nb-BLPs; G5, Fe-Bac-HlpA/EGFP-BLPs + AMF + CD47nb; G6, Fe-Bac-HlpA/CD47nb-BLPs + AMF. This evidence concerns the gene CD47 and neoplasm.